OBJECTIVES

To examine bacterial respiratory cultures in children with neurologic impairment (NI) (eg, cerebral palsy), both with and without tracheostomies, who were hospitalized with acute respiratory infections (ARIs) (eg, pneumonia) and to compare culture results across hospitals and age groups.

METHODS

This multicenter retrospective cohort study included ARI hospitalizations for children aged 1 to 18 years with NI between 2007 and 2012 who had a bacterial respiratory culture obtained within 2 days of admission. Data from 5 children’s hospitals in the Pediatric Health Information System Plus database were used. Organisms consistent with oral flora and nonspeciated organisms were omitted from analysis. The prevalence of positive respiratory culture results and the prevalence of organisms identified were compared across hospitals and age groups and in subanalyses of children with and without tracheostomies by using generalized estimating equations to account for within-patient clustering.

RESULTS

Of 4900 hospitalizations, 693 from 485 children had bacterial respiratory cultures obtained. Of these, 54.5% had positive results, although this varied across hospitals (range 18.6%–83.2%; P < .001). Pseudomonas aeruginosa and Staphylococcus aureus were the most commonly identified organisms across hospitals and age groups and in patients with and without tracheostomies. Large variation in growth prevalence was identified across hospitals but not age groups.

CONCLUSIONS

The bacteriology of ARI in hospitalized children with NI differs from that of otherwise healthy children. Significant variation in prevalence of positive bacterial respiratory culture results and organism growth were observed across hospitals, which may be secondary to local environmental factors and microbiology reporting practices.

Acute respiratory infections (ARIs) are the most common causes of hospitalization for children with neurologic impairment (NI) (eg, cerebral palsy).13  Antibiotic treatment strategies for this population often target respiratory bacteria implicated for ARI in otherwise healthy children. However, frequent hospital exposures and medical complexities common to children with NI, including respiratory technology dependence (eg, tracheostomy), may alter the bacterial causes of ARI.2,4  Although surveillance culture studies have revealed altered bacterial flora in adults and children with chronic conditions,59  less is known about the pathogenic causes of ARI in children with NI.

We sought to examine bacterial respiratory culture growth in children with NI, both with and without tracheostomies, hospitalized with ARI, comparing identified organisms across hospitals and age groups.

This multicenter retrospective cohort study included hospitalizations in Pediatric Health Information System Plus (PHIS+) (Children’s Hospital Association, Lenexa, KS). PHIS+ augmented Pediatric Health Information System data with detailed laboratory, microbiologic, and radiographic results from 6 children’s hospitals between 2007 and 2012.10,11  One hospital was excluded because of data quality concerns.

Hospitalizations for ARI in which a bacterial respiratory culture was obtained within 2 days of admission for children between 1 and 18 years of age with NI were included. NI was defined as a chronic neurologic diagnosis likely to result in substantial functional impairments.1214  Hospitalizations for ARI were identified by primary diagnosis codes within the Clinical Classifications Software (Agency for Healthcare Research and Quality, Rockville, MD) respiratory group indicative of ARI.15  Hospitalizations for children transferred from other hospitals and for children with HIV, with tuberculosis, or receiving chemotherapy were excluded.

We examined the first bacterial respiratory culture obtained. Cultures included specimens from bronchoalveolar lavage, endotracheal tubes, sputum, and tracheal aspirates. We excluded cultures identified as mouth, nasal, pharyngeal, and throat specimens, including saliva, to decrease likelihood of oral flora contamination. Microbiology laboratory guidelines were applied to all respiratory culture results to standardize across hospitals,16  which omitted organisms consistent with oral flora (eg, viridans group streptococci) and nonspeciated organisms (eg, Gram-negative rods). Results of bacterial respiratory cultures were classified as negative or positive with organisms identified.

To characterize the study population, patient demographics and medical complexity by using complex chronic conditions (CCCs)17,18  were examined. We calculated the prevalence of positive respiratory culture results and the prevalence of each organism identified with exact binomial 95% confidence intervals. Using Rao-Scott χ2 tests to account for within-hospital and within-patient clustering, we compared the prevalence of positive culture results and of the prevalence each organism across the 5 hospitals and across age groups (1–5, 6–12, and 13–18 years). Subsequently, we examined cultures in subanalyses of children with and without tracheostomies.18,19 P values <.05 were considered statistically significant. This study was approved by the institutional review board.

A total of 693 of 4900 (14.1%) hospitalizations of 485 children with NI and ARI had a bacterial respiratory culture obtained within 2 days of admission. Most cultures examined were from hospitalizations of children who were male (54.8%) and White (70.4%) and who had ≥3 CCCs (73.2%), had tracheostomies (54.7%), and were in the ICU at the time of culture collection (51.5%). Significant differences in several of these patient characteristics were noted across hospitals (Table 1).

TABLE 1

Cohort Demographics and Clinical Characteristics

Overall (N = 693)Hospital 1 (n = 113)Hospital 2 (n = 85)Hospital 3 (n = 209)Hospital 4 (n = 119)Hospital 5 (n = 167)Pa
Demographics        
 Age, median (IQR), y 6 (2–12) 4 (2–12) 7 (3–12) 4 (2–9) 7 (3–13) 6 (2–13) .014 
 Male sex 380 (54.8) 73 (64.6) 41 (48.2) 106 (50.7) 48 (40.3) 112 (67.1) .02 
 Race and/or ethnicity       <.001 
  Non-Hispanic White 488 (70.4) 87 (77.0) 48 (56.5) 172 (82.3) 46 (38.7) 135 (80.8) — 
  Non-Hispanic Black 100 (14.4) 3 (2.7) 9 (10.6) 33 (15.8) 38 (31.9) 17 (10.2) — 
  Hispanic 72 (10.4) 19 (16.8) 17 (20.0) 1 (0.5) 31 (26.1) 4 (2.4) — 
  Other 33 (4.8) 4 (3.5) 11 (12.9) 3 (1.4) 4 (3.4) 11 (6.6) — 
 Insurance type       <.001 
  Public 422 (60.9) 69 (61.1) 58 (58.2) 149 (71.3) 66 (55.5) 80 (47.9) — 
  Private 252 (36.4) 44 (38.9) 25 (29.4) 50 (23.9) 47 (39.5) 86 (51.5) — 
  Other 19 (2.7) 0 (0.0) 2 (2.4) 10 (4.8) 6 (5.0) 1 (0.6) — 
Clinical characteristics        
 Type of CCCs        
  Any 691 (99.7) 113 (100) 85 (100) 207 (99.0) 119 (100) 167 (100) .326 
  Gastrointestinal 530 (76.5) 96 (85.0) 64 (75.3) 145 (69.4) 86 (72.3) 139 (83.2) .015 
  Neuromuscular 484 (69.8) 66 (58.4) 56 (65.9) 161 (77.0) 80 (67.2) 121 (72.5) .195 
  Respiratory 462 (66.7) 96 (85.0) 64 (75.3) 127 (60.8) 54 (45.4) 121 (72.5) <.001 
  Genetic or Congenital 314 (45.3) 56 (49.6) 38 (44.7) 83 (39.7) 60 (50.4) 77 (46.1) .712 
  Cardiovascular 126 (18.2) 20 (17.7) 15 (17.6) 35 (16.7) 27 (22.7) 29 (17.4) .825 
  Renal 66 (9.5) 5 (4.4) 13 (15.3) 10 (4.8) 8 (6.7) 30 (18.0) <.001 
  Metabolic 59 (8.5) 2 (1.8) 5 (5.9) 25 (12.0) 14 (11.8) 13 (7.8) .028 
  Neonatal 55 (7.9) 8 (7.1) 5 (5.9) 24 (11.5) 14 (11.8) 4 (2.4) .023 
  Hematologic, Immunologic 32 (4.6) 4 (3.5) 2 (2.4) 4 (1.9) 8 (6.7) 14 (8.4) .052 
  Malignancy 19 (2.7) 3 (2.7) 4 (4.7) 1 (0.5) 7 (5.9) 4 (2.4) .188 
 No. CCCs       .055 
  0–1 58 (8.4) 7 (6.2) 7 (8.2) 21 (10.0) 14 (11.8) 9 (5.4) — 
  2 128 (18.5) 13 (11.5) 12 (14.1) 54 (25.8) 25 (21.0) 24 (14.4) — 
  3+ 507 (73.2) 93 (82.3) 66 (77.6) 134 (64.1) 80 (67.2) 134 (80.2) — 
 Tracheostomy dependenceb 379 (54.7) 88 (77.9) 55 (64.7) 103 (49.3) 35 (29.4) 98 (58.7) <.001 
 ICU at time of culture collection 357 (51.5) 49 (43.4) 29 (34.1) 149 (71.3) 67 (56.3) 63 (37.7) <.001 
 Culture source       <.001 
  Tracheostomy 449 (64.8) 99 (87.6) 64 (75.3) 171 (81.8) 37 (31.1) 78 (46.7) — 
  Endotracheal tube 29 (4.2) 0 (0.0) 3 (3.5) 0 (0.0) 0 (0.0) 26 (15.6) — 
  Bronchoalveolar lavage 52 (7.5) 6 (5.3) 3 (3.5) 12 (5.7) 7 (5.9) 24 (14.4) — 
  Other (eg, sputum) 163 (23.5) 8 (7.1) 15 (17.6) 26 (12.4) 75 (63.0) 39 (23.4) — 
 ARI diagnosis       <.001 
  Pneumonia 258 (37.2) 37 (32.7) 24 (28.2) 98 (46.9) 30 (25.2) 69 (41.3) — 
  Aspiration pneumonia 89 (12.8) 19 (16.8) 9 (10.6) 32 (15.3) 11 (9.2) 18 (10.8) — 
  Viral pneumonia or influenza 67 (9.7) 11 (9.7) 5 (5.9) 16 (7.7) 22 (18.5) 13 (7.8) — 
  Bronchiolitis or bronchitis 41 (5.9) 12 (10.6) 9 (10.6) 6 (2.9) 2 (1.7) 12 (7.2) — 
  Otherc 196 (28.3) 26 (23.0) 31 (36.5) 50 (23.9) 47 (39.5) 42 (25.1) — 
Overall (N = 693)Hospital 1 (n = 113)Hospital 2 (n = 85)Hospital 3 (n = 209)Hospital 4 (n = 119)Hospital 5 (n = 167)Pa
Demographics        
 Age, median (IQR), y 6 (2–12) 4 (2–12) 7 (3–12) 4 (2–9) 7 (3–13) 6 (2–13) .014 
 Male sex 380 (54.8) 73 (64.6) 41 (48.2) 106 (50.7) 48 (40.3) 112 (67.1) .02 
 Race and/or ethnicity       <.001 
  Non-Hispanic White 488 (70.4) 87 (77.0) 48 (56.5) 172 (82.3) 46 (38.7) 135 (80.8) — 
  Non-Hispanic Black 100 (14.4) 3 (2.7) 9 (10.6) 33 (15.8) 38 (31.9) 17 (10.2) — 
  Hispanic 72 (10.4) 19 (16.8) 17 (20.0) 1 (0.5) 31 (26.1) 4 (2.4) — 
  Other 33 (4.8) 4 (3.5) 11 (12.9) 3 (1.4) 4 (3.4) 11 (6.6) — 
 Insurance type       <.001 
  Public 422 (60.9) 69 (61.1) 58 (58.2) 149 (71.3) 66 (55.5) 80 (47.9) — 
  Private 252 (36.4) 44 (38.9) 25 (29.4) 50 (23.9) 47 (39.5) 86 (51.5) — 
  Other 19 (2.7) 0 (0.0) 2 (2.4) 10 (4.8) 6 (5.0) 1 (0.6) — 
Clinical characteristics        
 Type of CCCs        
  Any 691 (99.7) 113 (100) 85 (100) 207 (99.0) 119 (100) 167 (100) .326 
  Gastrointestinal 530 (76.5) 96 (85.0) 64 (75.3) 145 (69.4) 86 (72.3) 139 (83.2) .015 
  Neuromuscular 484 (69.8) 66 (58.4) 56 (65.9) 161 (77.0) 80 (67.2) 121 (72.5) .195 
  Respiratory 462 (66.7) 96 (85.0) 64 (75.3) 127 (60.8) 54 (45.4) 121 (72.5) <.001 
  Genetic or Congenital 314 (45.3) 56 (49.6) 38 (44.7) 83 (39.7) 60 (50.4) 77 (46.1) .712 
  Cardiovascular 126 (18.2) 20 (17.7) 15 (17.6) 35 (16.7) 27 (22.7) 29 (17.4) .825 
  Renal 66 (9.5) 5 (4.4) 13 (15.3) 10 (4.8) 8 (6.7) 30 (18.0) <.001 
  Metabolic 59 (8.5) 2 (1.8) 5 (5.9) 25 (12.0) 14 (11.8) 13 (7.8) .028 
  Neonatal 55 (7.9) 8 (7.1) 5 (5.9) 24 (11.5) 14 (11.8) 4 (2.4) .023 
  Hematologic, Immunologic 32 (4.6) 4 (3.5) 2 (2.4) 4 (1.9) 8 (6.7) 14 (8.4) .052 
  Malignancy 19 (2.7) 3 (2.7) 4 (4.7) 1 (0.5) 7 (5.9) 4 (2.4) .188 
 No. CCCs       .055 
  0–1 58 (8.4) 7 (6.2) 7 (8.2) 21 (10.0) 14 (11.8) 9 (5.4) — 
  2 128 (18.5) 13 (11.5) 12 (14.1) 54 (25.8) 25 (21.0) 24 (14.4) — 
  3+ 507 (73.2) 93 (82.3) 66 (77.6) 134 (64.1) 80 (67.2) 134 (80.2) — 
 Tracheostomy dependenceb 379 (54.7) 88 (77.9) 55 (64.7) 103 (49.3) 35 (29.4) 98 (58.7) <.001 
 ICU at time of culture collection 357 (51.5) 49 (43.4) 29 (34.1) 149 (71.3) 67 (56.3) 63 (37.7) <.001 
 Culture source       <.001 
  Tracheostomy 449 (64.8) 99 (87.6) 64 (75.3) 171 (81.8) 37 (31.1) 78 (46.7) — 
  Endotracheal tube 29 (4.2) 0 (0.0) 3 (3.5) 0 (0.0) 0 (0.0) 26 (15.6) — 
  Bronchoalveolar lavage 52 (7.5) 6 (5.3) 3 (3.5) 12 (5.7) 7 (5.9) 24 (14.4) — 
  Other (eg, sputum) 163 (23.5) 8 (7.1) 15 (17.6) 26 (12.4) 75 (63.0) 39 (23.4) — 
 ARI diagnosis       <.001 
  Pneumonia 258 (37.2) 37 (32.7) 24 (28.2) 98 (46.9) 30 (25.2) 69 (41.3) — 
  Aspiration pneumonia 89 (12.8) 19 (16.8) 9 (10.6) 32 (15.3) 11 (9.2) 18 (10.8) — 
  Viral pneumonia or influenza 67 (9.7) 11 (9.7) 5 (5.9) 16 (7.7) 22 (18.5) 13 (7.8) — 
  Bronchiolitis or bronchitis 41 (5.9) 12 (10.6) 9 (10.6) 6 (2.9) 2 (1.7) 12 (7.2) — 
  Otherc 196 (28.3) 26 (23.0) 31 (36.5) 50 (23.9) 47 (39.5) 42 (25.1) — 

IQR, interquartile range; N and n, number of cultures obtained and included in total and at each hospital; —, not applicable.

a

P value was determined by using χ2 tests for categorical variables and Wilcoxon rank tests for continuous variables, and to account for within-hospital and within-patient clustering, Rao-Scott χ2 tests were used.

b

Tracheostomy as defined by International Classification of Diseases, Ninth Revision, Clinical Modification codes 30.3, 30.4, 31.1, 31.2, 31.21, 31.29, 31.74, 33.21, 96.55, 97.23, 519.0, 519.01, 519.02, 519.09, V44.0, and V55.0.

c

Other ARI diagnosis type is any nonspecific diagnosis that might reflect an ARI (eg, acute chest syndrome, lung edema).

A total of 377 (54.5%) of 693 bacterial respiratory culture results were positive, revealing 19 different organisms. More than one-quarter (28.1%) were polymicrobial. The most common organisms were Pseudomonas aeruginosa (34.2%), Staphylococcus aureus (all strains, 20.6%; methicillin resistant, 5.1%), Serratia marcescens (9.4%), Haemophilus influenzae (8.5%), Streptococcus pneumoniae (7.9%), and Moraxella catarrhalis (6.2%). In the subanalysis of the 379 cultures from hospitalizations of children with tracheostomies, the results of 242 (63.9%) were positive. The most common organisms were P aeruginosa (42.0%), S aureus (all strains, 22.4%; methicillin resistant, 5.3%), S marcescens (14.8%), S pneumoniae (10.8%), H influenzae (9.8%), and Stenotrophomonas maltophilia (9.8%). In the subanalysis of the 314 cultures from hospitalizations of children without tracheostomies, the results of 135 (43%) were positive. The most common organisms were P aeruginosa (24.8%), S aureus (all strains, 18.5%; methicillin resistant, 4.8%), H influenzae (7%), S pneumoniae (4.5%), M catarrhalis (3.5%), and group B Streptococcus (3.2%).

The prevalence of positive respiratory culture results ranged from 18.6% to 83.2% across the 5 hospitals (P < .001). Polymicrobial culture growth ranged from 1.8% to 54.1% (P < .001). In Fig 1A, we illustrate the significant variation in organism prevalence across hospitals, with the exception of S pneumoniae. In the subanalysis of children with tracheostomies, the prevalence of positive respiratory culture results ranged from 21.4% to 87.5% (P < .001); the most common organisms had significant variation across hospitals (Fig 1B). In the subanalysis of children without tracheostomies, the prevalence of positive respiratory culture results ranged from 14.5% to 70.0% (P < .001). There was significant variation across hospitals for the most common organisms, except S pneumoniae and M catarrhalis (Fig 1C).

FIGURE 1

Comparison of respiratory culture results across hospitals. A, Full cohort of children with NI. B, Subanalysis of children with NI with tracheostomies. C, Subanalysis of children with NI without tracheostomies. Of note, n is the number of cultures obtained and included at each hospital (denominators). aStatistically significant difference among hospitals (P ≤ .001). bStatistically significant difference among hospitals (.001 < P < .05). cNo statistically significant difference among hospitals (P > .05). dNo statistically significant difference among hospitals (P > .1).

FIGURE 1

Comparison of respiratory culture results across hospitals. A, Full cohort of children with NI. B, Subanalysis of children with NI with tracheostomies. C, Subanalysis of children with NI without tracheostomies. Of note, n is the number of cultures obtained and included at each hospital (denominators). aStatistically significant difference among hospitals (P ≤ .001). bStatistically significant difference among hospitals (.001 < P < .05). cNo statistically significant difference among hospitals (P > .05). dNo statistically significant difference among hospitals (P > .1).

Close modal

The prevalence of positive respiratory culture results was similar across ages; prevalence was 60.3% for 6 to 12 years, 54.0% for 1 to 5 years, and 47.5% for 13 to 18 years (P = .141). Polymicrobial growth ranged from 22.8% to 31.4% (P = .203). In Fig 2A, we illustrate no significant variation in prevalence for the most common organisms across age groups, except M catarrhalis. In the subanalysis of children with tracheostomies, the prevalence of positive respiratory culture results ranged from 57.1% to 70.4% (P = .255). The most common organisms identified and lack of variation of prevalence across age groups paralleled that of the entire cohort, except for H influenzae (Fig 2B). In the subanalysis of children without tracheostomies, the prevalence of positive respiratory culture results ranged from 41.4% to 45.4% (P = .906). Of the most common organisms, only M catarrhalis had significant variation in prevalence across ages (P = .016; Fig 2C).

FIGURE 2

Comparison of respiratory culture results across age groups. A, Full cohort of children with NI. B, Subanalysis of children with NI with tracheostomies. C, Subanalysis of children with NI without tracheostomies. Of note, n is the number of cultures obtained and included for each age (denominators). a No statistically significant difference among age groups (P > .1). b Statistically significant difference among age groups (P ≤ .001). c Statistically significant difference among age groups (.001 < P < .05). d No statistically significant difference among age groups (P > .05).

FIGURE 2

Comparison of respiratory culture results across age groups. A, Full cohort of children with NI. B, Subanalysis of children with NI with tracheostomies. C, Subanalysis of children with NI without tracheostomies. Of note, n is the number of cultures obtained and included for each age (denominators). a No statistically significant difference among age groups (P > .1). b Statistically significant difference among age groups (P ≤ .001). c Statistically significant difference among age groups (.001 < P < .05). d No statistically significant difference among age groups (P > .05).

Close modal

In this multicenter study, the results of just over half of the bacterial respiratory cultures obtained from children with NI who required hospitalization for ARI were positive. P aeruginosa and S aureus were the most commonly identified organisms across hospitals and age groups and in patients with and without tracheostomies. There was significant variation in the prevalence of positive respiratory culture results, polymicrobial growth, and specific organism growth across hospitals but not age groups.

In our study, the 2 predominant pathogens of bacterial ARI in otherwise healthy children, S pneumoniae and H influenzae,20,21  were among the commonly identified organisms; however, the higher prevalence of P aeruginosa and S aureus identified in this study suggests a different epidemiology of bacterial ARI in children with NI compared with otherwise healthy children. Children with NI experience frequent hospitalizations and frequent antibiotic use and are often dependent on technology, all of which are known to increase antibiotic resistance, colonization, and infection risk with typical and atypical organisms.19,2228  As these exposures increase with time in children with NI, we hypothesize that older children and those with tracheostomies will be more likely to have positive culture results. However, positivity rates and organism prevalence remained similar across age groups. Children with NI and tracheostomies had higher rates of positive culture results. The most commonly identified organisms in children with and without tracheostomies were P aeruginosa and S aureus. Although it is possible these organisms could represent chronically colonizing bacteria rather than the bacterial cause of ARI, colonizing bacterial flora can become pathogenic sources of infection29,30  and are often treated as such given the lack of criteria or testing to distinguish between acute and chronic organisms on respiratory cultures. Hence, although our data support some differences in bacteriology when tracheostomy is present, we believe coverage of P aeruginosa and S aureus should be considered for all children with NI hospitalized with concern for bacterial ARI. Larger studies are necessary to better elucidate both the epidemiology and outcomes of ARI in this population, including treatment strategies and the comparative effectiveness of those antibiotic strategies.

Variation in the rate of positive respiratory culture results and in prevalence of isolated organisms during ARI may be related to differences in populations among the hospitals and local environmental factors (eg, infection control policies, local epidemiology). Similar institutional variability of infectious epidemiology has been described for ventilator-associated pneumonia3133  and bacteremia34  in adults. In our study, differences in patient characteristics across hospitals (eg, demographics, degree of illness as noted by the ICU at the time of culture collection, and tracheostomy presence) likely contribute to some of the variation in culture results across hospitals. However, the majority of the most common organisms continued to have significantly different prevalence across hospitals when analyzing the hospitalizations of children both with and without tracheostomies. Furthermore, patient complexity, as measured by CCC count, was similar across hospitals with higher and hospitals with lower positivity rates.

Another factor that may contribute to the respiratory culture variation noted in this study was microbiology reporting practices at the 5 hospital laboratories. Because we did not complete a formal assessment of the reporting practices at the various institutions, we can only speculate on the differences on the basis of the culture results reported and our own institution protocols for respiratory culture reporting. Several hospitals appeared to use stringent laboratory reporting protocols, in which clinically nonsignificant and nonpathogenic results were not reported (eg, P aeruginosa plus the terminology “oral flora”), whereas other hospitals seemed to report most or all organisms isolated (eg, P aeruginosa, viridans group streptococci, and Gram-negative rods), regardless of growth quantity or clinical significance. In this study, we attempted to limit the effects of these noted differences by standardizing results across hospitals with the application of laboratory guidelines. However, reporting variation across institutions remains a challenge in studying respiratory cultures and must be considered in when designing and evaluating results of future multicenter studies.

This study has several limitations. Given the retrospective and descriptive study design using limited data included in PHIS+, residual confounding (including previous cultures or nursing home resident status) likely exists. Inclusion of these variables would unlikely change the absolute prevalence of positive culture results. PHIS+ data are limited to 2007–2012; it is possible that practice change in obtaining respiratory cultures over the last decade could alter the frequency of culture positivity or the frequency of specific organisms identified. However, published national guidelines for the diagnosis of ARIs continue to exclude children with NI.20,35  Although there is growing awareness of diagnostic stewardship in the context of high-value care and it is possible that individual practitioners have altered their behaviors over the past decade,36,37  we are unaware of any institutional-level efforts or literature revealing practice change in this population. To limit the inclusion of hospital-acquired infections, we only examined respiratory cultures obtained within the first 2 days of hospitalization. In addition, because of limitations in the database regarding viral studies, we were unable to analyze possible viral coinfection. Thus, our results may not reflect the entirety of ARIs in children with NI.

In this multicenter cohort of hospitalizations for ARI in children with NI, there was significant variation in prevalence of positive culture results and organisms across hospitals. P aeruginosa and S aureus were the most commonly identified organisms during ARI, regardless of a child’s age or tracheostomy dependence. Children with NI may have different bacterial causes of ARI compared with otherwise healthy children; further studies are necessary to better understand the comparative effectiveness of antibiotic therapy strategies in the context of respiratory culture organism growth.

FUNDING: Dr Thomson was supported by the Agency for Healthcare Research and Quality (AHRQ) under award K08HS025138. Creation of the Pediatric Health Information System Plus database was supported by the AHRQ under award R01HS019862. The content is solely the responsibility of the authors and does not necessarily represent the official views of the AHRQ. The funder did not participate in the work.

Drs Warniment and Steuart contributed to the conceptualization and design of the study, participated in data cleaning, assisted with data analysis and interpretation, drafted the initial manuscript, and reviewed and revised the manuscript critically for important intellectual content; Mr Rodean and Dr Hall designed the statistical approach for this study, performed data analysis, interpreted the data, and reviewed and revised the manuscript critically for important intellectual content; Ms Chinchilla performed data cleaning, assisted with data analysis and interpretation, and reviewed and revised the manuscript critically for important intellectual content; Drs Shah and Thomson conceptualized and designed the study, coordinated and supervised data collection and cleaning, interpreted the data, and reviewed and revised the manuscript critically for important intellectual content; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

1.
Berry
JG
,
Poduri
A
,
Bonkowsky
JL
, et al
.
Trends in resource utilization by children with neurological impairment in the United States inpatient health care system: a repeat cross-sectional study
.
PLoS Med
.
2012
;
9
(
1
):
e1001158
2.
Seddon
PC
,
Khan
Y
.
Respiratory problems in children with neurological impairment
.
Arch Dis Child
.
2003
;
88
(
1
):
75
78
3.
Havers
F
,
Fry
AM
,
Chen
J
, et al
.
Hospitalizations attributable to respiratory infections among children with neurologic disorders
.
J Pediatr
.
2016
;
170
:
135
141.e5
4.
Srivastava
R
,
Jackson
WD
,
Barnhart
DC
.
Dysphagia and gastroesophageal reflux disease: dilemmas in diagnosis and management in children with neurological impairment
.
Pediatr Ann
.
2010
;
39
(
4
):
225
231
5.
Thorburn
K
,
Jardine
M
,
Taylor
N
,
Reilly
N
,
Sarginson
RE
,
van Saene
HKF
.
Antibiotic-resistant bacteria and infection in children with cerebral palsy requiring mechanical ventilation
.
Pediatr Crit Care Med
.
2009
;
10
(
2
):
222
226
6.
Mobbs
KJ
,
van Saene
HK
,
Sunderland
D
,
Davies
PD
.
Oropharyngeal gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease
.
Respir Med
.
1999
;
93
(
8
):
540
545
7.
Fuxench-López
Z
,
Ramírez-Ronda
CH
.
Pharyngeal flora in ambulatory alcoholic patients: prevalence of gram-negative bacilli
.
Arch Intern Med
.
1978
;
138
(
12
):
1815
1816
8.
Mackowiak
PA
,
Martin
RM
,
Jones
SR
,
Smith
JW
.
Pharyngeal colonization by gram-negative bacilli in aspiration-prone persons
.
Arch Intern Med
.
1978
;
138
(
8
):
1224
1227
9.
Chang
FY
,
Singh
N
,
Gayowski
T
,
Wagener
MM
,
Marino
IR
.
Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection
.
Infect Control Hosp Epidemiol
.
1998
;
19
(
5
):
328
332
10.
Gouripeddi
R
,
Warner
PB
,
Mo
P
, et al
.
Federating clinical data from six pediatric hospitals: process and initial results for microbiology from the PHIS+ consortium
.
AMIA Annu Symp Proc
.
2012
;
2012
:
281
290
11.
Narus
SP
,
Srivastava
R
,
Gouripeddi
R
, et al
.
Federating clinical data from six pediatric hospitals: process and initial results from the PHIS+ Consortium
.
AMIA Annu Symp Proc
.
2011
;
2011
:
994
1003
12.
Thomson
J
,
Hall
M
,
Ambroggio
L
, et al
.
Aspiration and non-aspiration pneumonia in hospitalized children with neurologic impairment
.
Pediatrics
.
2016
;
137
(
2
):
e20151612
13.
Thomson
JE
,
Feinstein
JA
,
Hall
M
,
Gay
JC
,
Butts
B
,
Berry
JG
.
Identification of children with high-intensity neurological impairment
.
JAMA Pediatr
.
2019
;
173
(
10
):
989
991
14.
Berry
JG
,
Hall
M
,
Hall
DE
, et al
.
Inpatient growth and resource use in 28 children’s hospitals: a longitudinal, multi-institutional study
.
JAMA Pediatr
.
2013
;
167
(
2
):
170
177
15.
Steuart
R
,
Tan
R
,
Melink
K
, et al
.
Discharge before return to respiratory baseline in children with neurologic impairment
.
J Hosp Med
.
2020
;
15
(
9
):
531
537
16.
Miller
JM
,
Binnicker
MJ
,
Campbell
S
, et al
.
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology
.
Clin Infect Dis
.
2018
;
67
(
6
):
813
816
17.
Feudtner
C
,
Christakis
DA
,
Connell
FA
.
Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997
.
Pediatrics
.
2000
;
106
(
1 pt 2
):
205
209
18.
Feudtner
C
,
Feinstein
JA
,
Zhong
W
,
Hall
M
,
Dai
D
.
Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation
.
BMC Pediatr
.
2014
;
14
:
199
19.
Russell
CJ
,
Thurm
C
,
Hall
M
,
Simon
TD
,
Neely
MN
,
Berry
JG
.
Risk factors for hospitalizations due to bacterial respiratory tract infections after tracheotomy
.
Pediatr Pulmonol
.
2018
;
53
(
3
):
349
357
20.
Bradley
JS
,
Byington
CL
,
Shah
SS
, et al
;
Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
.
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America
.
Clin Infect Dis
.
2011
;
53
(
7
):
e25
e76
21.
Jain
S
,
Williams
DJ
,
Arnold
SR
, et al
;
CDC EPIC Study Team
.
Community-acquired pneumonia requiring hospitalization among U.S. children
.
N Engl J Med
.
2015
;
372
(
9
):
835
845
22.
Dellit
TH
,
Owens
RC
,
McGowan
JE
 Jr
, et al
;
Infectious Diseases Society of America; Society for Healthcare Epidemiology of America
.
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
.
Clin Infect Dis
.
2007
;
44
(
2
):
159
177
23.
Brueggemann
AB
.
Antibiotic resistance mechanisms among pediatric respiratory and enteric pathogens: a current update
.
Pediatr Infect Dis J
.
2006
;
25
(
10
):
969
973
24.
Goldman
JL
,
Newland
JG
.
New horizons for pediatric antibiotic stewardship
.
Infect Dis Clin North Am
.
2015
;
29
(
3
):
503
511
25.
Cline
JM
,
Woods
CR
,
Ervin
SE
,
Rubin
BK
,
Kirse
DJ
.
Surveillance tracheal aspirate cultures do not reliably predict bacteria cultured at the time of an acute respiratory infection in children with tracheostomy tubes
.
Chest
.
2012
;
141
(
3
):
625
631
26.
McCaleb
R
,
Warren
RH
,
Willis
D
,
Maples
HD
,
Bai
S
,
O’Brien
CE
.
Description of respiratory microbiology of children with long-term tracheostomies
.
Respir Care
.
2016
;
61
(
4
):
447
452
27.
Pérez-Losada
M
,
Graham
RJ
,
Coquillette
M
, et al
.
The temporal dynamics of the tracheal microbiome in tracheostomised patients with and without lower respiratory infections
.
PLoS One
.
2017
;
12
(
8
):
e0182520
28.
Pérez-Losada
M
,
Graham
RJ
,
Coquillette
M
, et al
.
Tracheal microbiota in patients with a tracheostomy before, during and after an acute respiratory infection
.
Pediatr Infect Dis J
.
2018
;
37
(
11
):
e269
e271
29.
van der Voort
PH
.
Abnormal flora and infection in critically ill patients
.
Swiss Med Wkly
.
2014
;
144
:
w14024
30.
Jarvis
WR
.
The epidemiology of colonization
.
Infect Control Hosp Epidemiol
.
1996
;
17
(
1
):
47
52
31.
Hurley
JC
.
World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression
.
BMC Infect Dis
.
2016
;
16
(
1
):
577
32.
Hurley
JC
.
World-wide variation in incidence of Staphylococcus aureus associated ventilator-associated pneumonia: a meta-regression
.
Microorganisms
.
2018
;
6
(
1
):
18
33.
Hurley
JC
.
Worldwide variation in Pseudomonas associated ventilator associated pneumonia. A meta-regression
.
J Crit Care
.
2019
;
51
:
88
93
34.
David
MZ
,
Daum
RS
,
Bayer
AS
, et al
.
Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections
.
Clin Infect Dis
.
2014
;
59
(
6
):
798
807
35.
Harris
M
,
Clark
J
,
Coote
N
, et al
;
British Thoracic Society Standards of Care Committee
.
British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011
.
Thorax
.
2011
;
66
(
suppl 2
):
ii1
ii23
36.
Quinonez
RA
,
Garber
MD
,
Schroeder
AR
, et al
.
Choosing wisely in pediatric hospital medicine: five opportunities for improved healthcare value
.
J Hosp Med
.
2013
;
8
(
9
):
479
485
37.
Reyes
MA
,
Etinger
V
,
Hall
M
, et al
.
Impact of the Choosing Wisely® campaign recommendations for hospitalized children on clinical practice: trends from 2008 to 2017
.
J Hosp Med
.
2020
;
15
(
2
):
68
74

Competing Interests

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.